Tag Archives: Thane Kreiner

Thane Kreiner, the Biotech-Entrepreneur-Turned-Educator With 1 Billion People on His Mind

Thane Kreiner, in the prime of his professional life at 50, could be doing pretty much whatever he wants in Silicon Valley’s biotech industry. But about a year ago, he took a job that offered him a big cut in salary, no stock options, and no performance bonuses. The lure? The chance to help build […]

Posted in National blog main, San Francisco, San Francisco blog main, San Francisco top stories | Tagged , , , , , , , , , , , , , , , , , , , | 3 Comments

SeaGen Passes FDA Panel, Ken Stuart’s Journey to Seattle Biomed, the Latest M&A Obsession, & More Seattle-Area Life Sciences News

This was the week Seattle Genetics passed an important milestone on its way to bringing its first product to the U.S. market. —Seattle Genetics (NASDAQ: SGEN) won unanimous endorsement from an FDA advisory panel for its new drug for rare lymphomas, brentuximab vedotin (Adcetris). The FDA’s committee of cancer drug experts voted 10-0 in favor […]

Posted in National blog main, Seattle, Seattle blog main | Tagged , , , , , , , , , , , , , , , , | Comments Off on SeaGen Passes FDA Panel, Ken Stuart’s Journey to Seattle Biomed, the Latest M&A Obsession, & More Seattle-Area Life Sciences News

How a VC-Style Investment System Can Support a More Just and Humane World

If you were to look under the hood of any big-name IPO these days – such as LinkedIn, Pandora, and someday, Facebook – you’d see a highly sophisticated coordination of capital sources that fueled each to that highly coveted spot: Seed or “Angel” money that got the idea off the ground was followed by early-stage […]

Posted in Boston Xcon, Detroit Xcon, National, National Xcon, New York Xcon, San Diego Xcon, San Francisco Xcon, Seattle Xcon | Tagged , , , , , , , , , , , , , , | 1 Comment

iPierian, Stem Cell Startup With Big Science & Big Bucks, Axes Group of Top Executives

The board of iPierian, the South San Francisco-based stem cell company with high-profile scientific founders from Harvard University and prominent financial backers that include GlaxoSmithKline, Kleiner Perkins Caufield & Byers, Google Ventures, and Biogen Idec, has terminated several members of the company’s senior executive team as part of a shift in strategy, Xconomy has learned. […]

Posted in Boston blog main, Boston top stories, National blog main, San Francisco, San Francisco blog main, San Francisco top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 2 Comments

PhyloTech, Corey Goodman’s First Environmental Health Startup, Raises $1.2M in Seed Capital

Corey Goodman, the prominent biotech entrepreneur, looked at the view from his home at Tomales Bay in Marin County, CA one day in the late ’90s, and was stunned by what he saw. Officials were taking water samples, looking for bacterial contamination that was making people sick. It was all a big mystery where it […]

Posted in National blog main, San Francisco, San Francisco blog main, San Francisco top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 2 Comments

Presage Biosciences, the Fred Hutch Spinoff, Adds CEO, Angel Bucks, Big Pharma Customers

Quite a lot has happened at Presage Biosciences in just a couple months. This Seattle-based company, a spinoff from the Fred Hutchinson Cancer Research Center, has recruited a new CEO, raised another $1 million, found new labs, and snapped up two active contracts from Big Pharma customers. Such are the heady early days for the […]

Posted in National blog main, Seattle, Seattle blog main, Seattle top stories | Tagged , , , , , , , , , , , , , , , | 2 Comments

Presage, a Hutch Spinoff, Raises $3M From Angels to Boost Cancer Drug Hit Rate

Seattle-based Presage Biosciences has a big dream for a biotech startup—and now it has seed capital to put that dream to the test. Presage, a spinoff from the Fred Hutchinson Cancer Research Center, is announcing today it has raised $3.1 million from angel investors to get the company off the ground at a $5 million […]

Posted in National blog main, Seattle, Seattle blog main | Tagged , , , , , , , , , , , , , , , , | 4 Comments

Presage, Fred Hutch Spinoff, Aims to Show Docs Which Cancer Drugs Work, and Which Won’t

Cancer drugs make almost everyone sick as a dog from toxic side effects, yet they have a hit-or-miss record when it comes to killing cancer cells. Jim Olson is a pediatric oncologist, so he’s well aware of the suffering and waste created by this approach. He prescribes these nasty toxins for young kids with only […]

Posted in National blog main, Seattle, Seattle blog main | Tagged , , , , , , , , , , , , , , | Comments Off on Presage, Fred Hutch Spinoff, Aims to Show Docs Which Cancer Drugs Work, and Which Won’t